Effects of microvascular decompression of the pterygpalatine ganglion in patients with persistent, drug-resistent, Cluster headache: a pilot study.

Effects of microvascular decompression of the pterygpalatine ganglion in patients with persistent, drug-resistent, Cluster headache: a pilot study. - Microvascular decompression for Cluster headache.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30519

Enrollment

Registered

2007-03-13

Start date

2009-03-01

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Horton's neuralgia

Interventions

Microvascular decompression of the pterygopalatine ganglion by means of insertion of a piece of temporal muscle between the pterygopalatine ganglion and the maxillary artery and clipping of the arte

to ensure discontinuation of contact between the pterygopalatine ganglion and the maxillary artery.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: persistent, drug-resistant, Cluster headache patients diagnosed and treated farmacologically at Headache Group of Leiden Universitary Medical Centre

Exclusion criteria

Exclusion criteria: major anatomical variations in the area of interest disease of maxillary sinus previous surgery in the area of interest pain attributable to other diagnosis

Design outcomes

Primary

Measure	Time frame
Primary outcome measure will be the severity of pain assessed on a Visual Analogue Scale and the mean duration of pain per week in hours.	—

Secondary

Measure	Time frame
Secondary outcome measure will be quality of life, assessed with the SF-36 Health Survey and EuroQol questionnaire.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)